Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Oculgen Biomedical Technology Co., Ltd.

Clinical trials sponsored by Shenzhen Oculgen Biomedical Technology Co., Ltd., explained in plain language.

Not yet recruiting 1

New eye drug aims to block two causes of vision loss at once

Disease control Not yet recruiting

This study tests an investigational drug called OCUL101 for people with wet age-related macular degeneration (AMD), a condition that causes blurry vision and can lead to blindness. OCUL101 targets two proteins involved in the disease to reduce abnormal blood vessel growth and inf…

Phase: PHASE2, PHASE3 • Sponsor: Shenzhen Oculgen Biomedical Technology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC